XML 114 R115.htm IDEA: XBRL DOCUMENT v3.3.0.814
Segment Information (Segment Results) (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2014
Sep. 26, 2014
Jun. 27, 2014
Mar. 28, 2014
Dec. 31, 2013
Sep. 27, 2013
Jun. 28, 2013
Mar. 29, 2013
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Sales $ 5,224.2 $ 4,707.1 $ 4,783.5 $ 4,439.2 $ 5,044.0 $ 4,479.4 $ 4,534.1 $ 4,225.6 $ 19,154.0 $ 18,283.1 $ 17,474.8
Operating profit 866.8 $ 866.2 $ 875.5 $ 738.1 854.9 $ 783.8 $ 804.8 $ 677.0 3,346.6 3,120.5 2,979.6
Identifiable assets 36,991.7       34,672.2       36,991.7 34,672.2 32,941.0
Depreciation and amortization                 889.5 850.6 799.0
Capital expenditures, gross                 580.6 538.1 445.8
Test & Measurement                      
Sales                 2,702.1 2,582.4 2,595.4
Operating profit                 573.2 515.1 515.7
Depreciation and amortization                 83.5 90.7 91.5
Capital expenditures, gross                 17.0 25.4 25.0
Environmental                      
Sales                 3,547.3 3,316.9 3,063.5
Operating profit                 705.2 696.5 652.5
Depreciation and amortization                 85.7 62.7 48.9
Capital expenditures, gross                 76.1 46.5 29.5
Life Sciences & Diagnostics                      
Sales                 7,185.7 6,856.4 6,485.1
Operating profit                 1,105.9 1,009.8 861.1
Depreciation and amortization                 539.0 517.3 478.2
Capital expenditures, gross                 391.1 386.7 296.8
Dental                      
Sales                 2,193.1 2,094.9 2,022.9
Operating profit                 304.4 304.9 293.1
Depreciation and amortization                 85.0 83.3 92.4
Capital expenditures, gross                 24.4 30.7 30.2
Industrial Technologies                      
Sales                 3,525.8 3,432.5 3,307.9
Operating profit                 801.3 722.9 685.6
Depreciation and amortization                 88.8 89.2 80.8
Capital expenditures, gross                 70.6 47.1 49.0
Equity method earnings related to Apex joint venture                      
Operating profit                 0.0 0.0 69.9
Other Segments                      
Operating profit                 (143.4) (128.7) (98.3)
Depreciation and amortization                 7.5 7.4 7.2
Capital expenditures, gross                 1.4 1.7 15.3
Continuing operations | Test & Measurement                      
Identifiable assets 3,550.9       3,561.6       3,550.9 3,561.6 3,619.5
Continuing operations | Environmental                      
Identifiable assets 3,824.9       3,584.5       3,824.9 3,584.5 3,146.6
Continuing operations | Life Sciences & Diagnostics                      
Identifiable assets 13,743.9       13,614.7       13,743.9 13,614.7 13,305.2
Continuing operations | Dental                      
Identifiable assets 6,224.3       4,095.1       6,224.3 4,095.1 4,079.9
Continuing operations | Industrial Technologies                      
Identifiable assets 4,149.0       4,363.6       4,149.0 4,363.6 4,235.6
Continuing operations | Other Segments                      
Identifiable assets 3,615.2       3,519.3       3,615.2 3,519.3 2,667.9
Discontinued operations                      
Identifiable assets $ 1,883.5       $ 1,933.4       $ 1,883.5 $ 1,933.4 $ 1,886.3